Riku Turkki
Cited by
Cited by
Deep learning based tissue analysis predicts outcome in colorectal cancer
D Bychkov, N Linder, R Turkki, S Nordling, PE Kovanen, C Verrill, ...
Scientific reports 8 (1), 1-11, 2018
Identification of tumor epithelium and stroma in tissue microarrays using texture analysis
N Linder, J Konsti, R Turkki, E Rahtu, M Lundin, S Nordling, C Haglund, ...
Diagnostic pathology 7 (1), 22, 2012
Phase I study with ONCOS-102 for the treatment of solid tumors–an evaluation of clinical response and exploratory analyses of immune markers
T Ranki, S Pesonen, A Hemminki, K Partanen, K Kairemo, T Alanko, ...
Journal for immunotherapy of cancer 4 (1), 1-18, 2016
A malaria diagnostic tool based on computer vision screening and visualization of Plasmodium falciparum candidate areas in digitized blood smears
N Linder, R Turkki, M Walliander, A Mårtensson, V Diwan, E Rahtu, ...
PLoS One 9 (8), e104855, 2014
Systems pathology by multiplexed immunohistochemistry and whole-slide digital image analysis
S Blom, L Paavolainen, D Bychkov, R Turkki, P Mäki-Teeri, A Hemmes, ...
Scientific Reports 7 (1), 1-13, 2017
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices
EJ Davies, M Dong, M Gutekunst, K Närhi, HJAA Van Zoggel, S Blom, ...
Scientific reports 5 (1), 1-17, 2015
Antibody-supervised deep learning for quantification of tumor-infiltrating immune cells in hematoxylin and eosin stained breast cancer samples
R Turkki, N Linder, PE Kovanen, T Pellinen, J Lundin
Journal of pathology informatics 7, 2016
Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy
O Hemminki, S Parviainen, J Juhila, R Turkki, N Linder, J Lundin, ...
Oncotarget 6 (6), 4467, 2015
Repeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at …
L Vassilev, T Ranki, T Joensuu, E Jäger, J Karbach, C Wahle, K Partanen, ...
Oncoimmunology 4 (7), e1017702, 2015
Local treatment of a pleural mesothelioma tumor with ONCOS-102 induces a systemic antitumor CD8+ T-cell response, prominent infiltration of CD8+ lymphocytes and Th1 type …
T Ranki, T Joensuu, E Jäger, J Karbach, C Wahle, K Kairemo, T Alanko, ...
Oncoimmunology 3 (10), e958937, 2014
Immune cell contexture in the bone marrow tumor microenvironment impacts therapy response in CML
O Brück, S Blom, O Dufva, R Turkki, H Chheda, A Ribeiro, P Kovanen, ...
Leukemia 32 (7), 1643-1656, 2018
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus
K Taipale, I Liikanen, J Juhila, R Turkki, S Tähtinen, M Kankainen, ...
Molecular Therapy 24 (1), 175-183, 2016
Deep learning for tissue microarray image-based outcome prediction in patients with colorectal cancer
D Bychkov, R Turkki, C Haglund, N Linder, J Lundin
Medical Imaging 2016: Digital Pathology 9791, 979115, 2016
Assessment of tumour viability in human lung cancer xenografts with texture-based image analysis
R Turkki, N Linder, T Holopainen, Y Wang, A Grote, M Lundin, K Alitalo, ...
Journal of clinical pathology 68 (8), 614-621, 2015
Automated segmentation of blood cells in Giemsa stained digitized thin blood films
M Walliander, R Turkki, N Linder, M Lundin, J Konsti, V Ojansivu, T Meri, ...
Diagnostic Pathology 8 (S1), S37, 2013
Clonal heterogeneity influences drug responsiveness in renal cancer assessed by ex vivo drug testing of multiple patient‐derived cancer cells
K Saeed, P Ojamies, T Pellinen, S Eldfors, R Turkki, J Lundin, P Järvinen, ...
International journal of cancer 144 (6), 1356-1366, 2019
Immunological data from cancer patients treated with Ad5
O Hemminki, S Parviainen, J Juhila, R Turkki, N Linder, J Lundin, ...
Combined epithelial marker analysis of tumour budding in stage II colorectal cancer
K Slik, S Blom, R Turkki, K Välimäki, S Kurki, H Mustonen, C Haglund, ...
The Journal of Pathology: Clinical Research 5 (1), 63-78, 2019
ITGB1-dependent upregulation of Caveolin-1 switches TGFβ signalling from tumour-suppressive to oncogenic in prostate cancer
T Pellinen, S Blom, S Sánchez, K Välimäki, JP Mpindi, H Azegrouz, ...
Scientific reports 8 (1), 1-14, 2018
Immune cell constitution in bone marrow microenvironment predicts outcome in adult ALL
H Hohtari, O Brück, S Blom, R Turkki, M Sinisalo, PE Kovanen, ...
Leukemia 33 (7), 1570-1582, 2019
The system can't perform the operation now. Try again later.
Articles 1–20